Successful Use of Omalizumab for Insulin Hypersensitivity in a Child with Type 1 Diabetes: 3 Years of Follow-up. Martino M, Diakanthos M, Patrizi F, Cianfarani S, et al. Diabetes Care 2025 Oct 9:dc251743. doi: 10.2337/dc25-1743.

Read + Share

Amedeo Smart

Independent Medical Education

Martino M, Diakanthos M, Patrizi F, Cianfarani S, et al. Successful Use of Omalizumab for Insulin Hypersensitivity in a Child with Type 1 Diabetes: 3 Years of Follow-up. Diabetes Care 2025 Oct 9:dc251743. doi: 10.2337/dc25-1743.
PMID: 41066718